A comprehensive on-site review of your current processes is necessary to identify areas of risk.
Federal and state laws address the need for controlled substance monitoring and reporting
Much time and energy may be devoted to monitoring for drug diversion, and once suspected,
Federal and state laws address the need for controlled substance monitoring and reporting
As Rxpert Solutions’ lead consultant, Terri Vidals has years of experience in drug diversion monitoring
For many, the holidays are a time of struggle. The reason for the struggle varies. I am hoping at least one person struggling with substance
In the fast-paced world of healthcare, where decisions can have life-altering consequences, the terms “accountability” and “responsibility” often get thrown around interchangeably. However, these two
Health Care Diversion
https://healthcarediversion.org
DEA Office of Diversion Control
https://www.deadiversion.usdoj.gov/
International Health Facility Diversion Association
https://ihfda.org/
Opioid prescribing
https://www.teaterhs.com/
Jenn, RN, MSN, CNAMB Manager of Clinic Operations
Doug, MD Anesthesiologist
No supervisor wants to hear that data indicates one of their employees may be diverting controlled substances. However, when they do, every supervisor owes it to their patients and their employees to thoroughly investigate in an effort to confirm or rule out that suspicion. Today’s guests did exactly that. Get an inside look at their thoughts and feelings through the process.
Terri has been a pharmacist for over 30 years and is a drug diversion mitigation and monitoring subject matter expert. Her years of experience in various roles within hospital pharmacy have given her real-world insight into risk, compliance, and regulatory requirements, as well as best practices for medication and patient safety.
Subscribe to Drug Diversion Insights with Terri Vidals to learn more about diversion mitigation.
© Copyright 2023. All Rights Reserved.